4 Near term news flow around Mid 2024(I assume it means July, not September):
1. Pan-LOX scar
prevention for burn
injuries- clinical
trial commences
recruitment.
2. SNT-5505 Phase 2a
myelofibrosis
combination study
(add on to JAK
inhibitor)
completes
recruitment
3. Syntara skin
scarring clinical
development plan
announced
4. SNT-4728 iRBD /
neuro
inflammation study
recruitment
update
Ann: Investor presentation, page-9
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.001(2.86%) |
Mkt cap ! $43.87M | |||
| Open | High | Low | Value | Volume |
| 3.5¢ | 3.5¢ | 3.4¢ | $14.00K | 402.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 440288 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 374403 | 3 |
View Market Depth
| Last trade - 15.50pm 30/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |